Quarterly report pursuant to Section 13 or 15(d)

The following sets forth the number of shares of Common Stock underlying outstanding convertible preferred stock, options, warrants, and convertible notes that have been excluded from the computation of loss per common share (Details)

v3.22.0.1
The following sets forth the number of shares of Common Stock underlying outstanding convertible preferred stock, options, warrants, and convertible notes that have been excluded from the computation of loss per common share (Details) - shares
9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 22,330,785 38,315,634
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount [1] 13,500,000 16,300,000
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8,830,785 6,769,635
Convertible Notes [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 245,999
Series A Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (0) 15,000,000
[1] The Company has excluded 4,500,000 stock options, with an exercise price of $0.0004, from its anti-dilutive securities as these shares have been included in our determination of basic loss per share as they represent shares issuable for little or no cash consideration upon the satisfaction of certain conditions pursuant to ASC 260-10-45-14.